Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1995-6-20
pubmed:abstractText
A previous report of a large, double blind, efficacy trial of an experimental Group B meningococcal outer membrane protein vaccine carried out in Norwegian Teenagers, showed a protection rate of 57%. Previous studies had demonstrated the occurrence of mutations in the class-1 outer membrane protein which alter its immunological properties. The occurrence of new mutations might compromise the efficacy of a vaccine and explain the occurrence of any vaccine failures. The porA gene, which encodes expression of the class 1 protein, was sequenced in all isolates from vaccine failures and compared to that of the vaccinating strain H44/76 (B:15:P1.7,16). The porA DNA and deduced amino acid sequences were all identical to that of the vaccinating strain except for that of one isolate which had a sequence identical to strains previously reported in Norway and England with a 'masked P1.7' epitope. The absence of new mutations in the trial was encouraging for the further development of outer membrane protein vaccines.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0882-4010
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
425-30
pubmed:dateRevised
2011-4-7
pubmed:meshHeading
pubmed-meshheading:7752883-Adolescent, pubmed-meshheading:7752883-Amino Acid Sequence, pubmed-meshheading:7752883-Bacterial Capsules, pubmed-meshheading:7752883-Bacterial Vaccines, pubmed-meshheading:7752883-DNA, Bacterial, pubmed-meshheading:7752883-Female, pubmed-meshheading:7752883-Gene Expression Regulation, Bacterial, pubmed-meshheading:7752883-Humans, pubmed-meshheading:7752883-Immunotherapy, Active, pubmed-meshheading:7752883-Male, pubmed-meshheading:7752883-Meningococcal Infections, pubmed-meshheading:7752883-Molecular Sequence Data, pubmed-meshheading:7752883-Mutation, pubmed-meshheading:7752883-Neisseria meningitidis, pubmed-meshheading:7752883-Norway, pubmed-meshheading:7752883-Polysaccharides, Bacterial, pubmed-meshheading:7752883-Porins, pubmed-meshheading:7752883-Treatment Failure
pubmed:year
1994
pubmed:articleTitle
Comparison of the class-1 outer membrane protein from B:15:P1.16 Neisseria meningitidis strains isolated from patients previously immunized with a serogroup B outer membrane protein vaccine in Norway.
pubmed:affiliation
University of Southampton Medical School, Southampton General Hospital, UK.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, Non-U.S. Gov't